Transmedics Acquires Warm Perfusion EVOSS And Cold Perfusion LifeCradle Technologies From Bridge To Life; Terms Not Disclosed
Portfolio Pulse from Benzinga Newsdesk
Transmedics has acquired warm perfusion EVOSS and cold perfusion LifeCradle technologies from Bridge To Life. The terms of the deal were not disclosed.
August 04, 2023 | 12:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Transmedics has expanded its product portfolio by acquiring EVOSS and LifeCradle technologies from Bridge To Life. The financial details of the deal were not disclosed.
The acquisition of EVOSS and LifeCradle technologies by Transmedics is likely to expand its product portfolio and potentially increase its market share. This could lead to increased revenues and profitability in the future, which is generally positive for the stock price. However, the lack of financial details makes it difficult to fully assess the impact of the deal.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100